| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada
IL-13, a Th2 cytokine, exhibits similar functions to IL-4 in stimulating proliferation and class switching of human B cells. Although mouse B cells were reported to be unresponsive to IL-13, we now show that IL-13 directly stimulates mouse B cells, causing extended survival and higher Ab levels. Recombinant mouse IL-13 was administered via osmotic pump during immunization of BALB/c mice with chicken RBCs. IL-13 treatment enhanced not only the plasma levels of total IgG1, IgG2a, and IgG2b but also Ag-specific Ig levels. To examine whether IL-13 acted directly on mouse B cells, B220+ B cells were cultured with fixed, anti-CD3-activated Th2 clones. Production of IgM and IgG1 was enhanced moderately by IL-13 and strongly by IL-4. Anti-CD40-stimulated sIgD+ mouse B cells also responded to IL-13 by producing increased levels of IgM, and to a lesser extent IgG1, IgG2a, IgG2b, and IgG3. No evidence was found for IL-13-induced class switching. Mouse B cells were stimulated directly rather than indirectly via contaminating cells, as IL-13 increased the numbers of both total and Ab-secreting B cells in aliquots of 100 sIgD+ B cells (>99.5% pure) stimulated with anti-CD40 Ab. Stimulation of B cells by IL-13 was unaffected by the addition of anti-IL-4 to the cultures. In contrast to IL-4, IL-13 did not increase CD23 expression or B cell proliferation as measured by dilution of an intracellular fluorescence label. Collectively, these data indicate that IL-13 can enhance mouse B cell Ab production by increasing survival of the B cells.
This article has been cited by other articles:
|
|
 |
|
  Y. Ma, K. T. HayGlass, A. B. Becker, Y. Fan, X. Yang, S. Basu, G. Srinivasan, F. E. R. Simons, A. J. Halayko, and Z. Peng Novel Recombinant Interleukin-13 Peptide-based Vaccine Reduces Airway Allergic Inflammatory Responses in Mice Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. O'Brien-Simpson, R. D. Pathirana, R. A. Paolini, Y.-Y. Chen, P. D. Veith, V. Tam, N. Ally, R. N. Pike, and E. C. Reynolds An Immune Response Directed to Proteinase and Adhesin Functional Epitopes Protects against Porphyromonas gingivalis-Induced Periodontal Bone Loss J. Immunol., September 15, 2005; 175(6): 3980 - 3989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tamauchi, M. Terashima, M. Ito, H. Maruyama, N. Ikewaki, M. Inoue, X. Gao, K. Hozumi, and S. Habu Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response Int. Immunol., January 1, 2004; 16(1): 179 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Wood, M. J. Whitters, B. A. Jacobson, J. Witek, J. P. Sypek, M. Kasaian, M. J. Eppihimer, M. Unger, T. Tanaka, S. J. Goldman, et al. Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor {alpha} 2 J. Exp. Med., March 17, 2003; 197(6): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Bajer, D. Garcia-Tapia, K. R. Jordan, K. M. Haas, D. Werling, C. J. Howard, and D. M. Estes Peripheral blood-derived bovine dendritic cells promote IgG1-restricted B cell responses in vitro J. Leukoc. Biol., January 1, 2003; 73(1): 100 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-B. Haddad, S. L. Underwood, D. Dabrowski, M. A. Birrell, K. McCluskie, C. H. Battram, M. Pecoraro, M. L. Foster, and M. G. Belvisi Critical Role for T Cells in Sephadex-Induced Airway Inflammation: Pharmacological and Immunological Characterization and Molecular Biomarker Identification J. Immunol., March 15, 2002; 168(6): 3004 - 3016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tomkinson, C. Duez, G. Cieslewicz, J. C. Pratt, A. Joetham, M.-C. Shanafelt, R. Gundel, and E. W. Gelfand A Murine IL-4 Receptor Antagonist That Inhibits IL-4- and IL-13-Induced Responses Prevents Antigen-Induced Airway Eosinophilia and Airway Hyperresponsiveness J. Immunol., May 1, 2001; 166(9): 5792 - 5800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Andrews, L. R. Rosa, M. O. Daines, and G. K. Khurana Hershey Reconstitution of a Functional Human Type II IL-4/IL-13 Receptor in Mouse B Cells: Demonstration of Species Specificity J. Immunol., February 1, 2001; 166(3): 1716 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Ehigiator, A. W. Stadnyk, and T. D. G. Lee Extract of Nippostrongylus brasiliensis Stimulates Polyclonal Type-2 Immunoglobulin Response by Inducing De Novo Class Switch Infect. Immun., September 1, 2000; 68(9): 4913 - 4922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Constant, C. Dong, D. D. Yang, M. Wysk, R. J. Davis, and R. A. Flavell JNK1 Is Required for T Cell-Mediated Immunity Against Leishmania major Infection J. Immunol., September 1, 2000; 165(5): 2671 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. O'Brien-Simpson, R. A. Paolini, and E. C. Reynolds RgpA-Kgp Peptide-Based Immunogens Provide Protection against Porphyromonas gingivalis Challenge in a Murine Lesion Model Infect. Immun., July 1, 2000; 68(7): 4055 - 4063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Johansson, S. Ingvarsson, P. Bjorck, and C. A. K. Borrebaeck Human Interdigitating Dendritic Cells Induce Isotype Switching and IL-13-Dependent IgM Production in CD40-Activated Naive B Cells J. Immunol., February 15, 2000; 164(4): 1847 - 1854. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
